Your browser doesn't support javascript.
loading
Prevalence of AAV1 neutralizing antibodies and consequences for a clinical trial of gene transfer for advanced heart failure.
Greenberg, B; Butler, J; Felker, G M; Ponikowski, P; Voors, A A; Pogoda, J M; Provost, R; Guerrero, J; Hajjar, R J; Zsebo, K M.
Afiliação
  • Greenberg B; Sulpizio Cardiovascular Center, University of California, San Diego, La Jolla, CA, USA.
  • Butler J; Stony Brook University, Stony Brook, NY, USA.
  • Felker GM; Duke University School of Medicine, Durham, NC, USA.
  • Ponikowski P; Wroclaw Medical University and Military Hospital, Wroclaw, Poland.
  • Voors AA; University of Groningen, Groningen, The Netherlands.
  • Pogoda JM; Celladon Corporation, San Diego, CA, USA.
  • Provost R; Celladon Corporation, San Diego, CA, USA.
  • Guerrero J; Celladon Corporation, San Diego, CA, USA.
  • Hajjar RJ; Cardiovascular Research Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Zsebo KM; Biovest Consulting, LLC, Santa Barbara, CA, USA.
Gene Ther ; 23(3): 313-9, 2016 Mar.
Article em En | MEDLINE | ID: mdl-26699914
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dependovirus / Vetores Genéticos / Insuficiência Cardíaca / Anticorpos Antivirais Tipo de estudo: Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dependovirus / Vetores Genéticos / Insuficiência Cardíaca / Anticorpos Antivirais Tipo de estudo: Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article